These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 36830706

  • 1. Plasma Neutrophil Gelatinase-Associated Lipocalin Associates with New-Onset Chronic Kidney Disease in the General Population.
    Bourgonje AR, Abdulle AE, Bourgonje MF, Kieneker LM, la Bastide-van Gemert S, Gordijn SJ, Hidden C, Nilsen T, Gansevoort RT, Mulder DJ, Dullaart RPF, de Borst MH, Bakker SJL, van Goor H.
    Biomolecules; 2023 Feb 09; 13(2):. PubMed ID: 36830706
    [Abstract] [Full Text] [Related]

  • 2. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.
    Am J Nephrol; 2015 Feb 09; 41(2):156-64. PubMed ID: 25824561
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA, Köttgen A, Coresh J, Astor BC.
    Am J Kidney Dis; 2012 Aug 09; 60(2):233-40. PubMed ID: 22542304
    [Abstract] [Full Text] [Related]

  • 4. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.
    Am J Kidney Dis; 2012 Dec 09; 60(6):904-11. PubMed ID: 22749388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) study investigators.
    Kidney Int; 2013 May 09; 83(5):909-14. PubMed ID: 23344473
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb 09; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case-control study in a regional hospital in Ghana.
    Danquah M, Owiredu WKBA, Jnr BAE, Serwaa D, Odame Anto E, Peprah MO, Obirikorang C, Fondjo LA.
    BMC Nephrol; 2023 Apr 26; 24(1):114. PubMed ID: 37101162
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
    Kim IY, Kim JH, Lee DW, Lee SB, Rhee H, Song SH, Seong EY, Kwak IS.
    Clin Exp Nephrol; 2018 Feb 26; 22(1):28-34. PubMed ID: 28389813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.
    Nephrology (Carlton); 2014 Mar 26; 19(3):129-35. PubMed ID: 24397346
    [Abstract] [Full Text] [Related]

  • 16. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M.
    Transplant Proc; 2009 Mar 26; 41(1):158-61. PubMed ID: 19249502
    [Abstract] [Full Text] [Related]

  • 17. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, Gok M, Cetinkaya H, Gaipov A, Eyileten T, Sari S, Yildirim AO, Tonbul HZ, Turk S, Covic A, Kanbay M.
    Int Urol Nephrol; 2015 Dec 26; 47(12):1993-2001. PubMed ID: 26498629
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C.
    Crit Care; 2014 Feb 28; 18(1):R39. PubMed ID: 24581340
    [Abstract] [Full Text] [Related]

  • 20. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 Feb 28; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.